
Illumina, Inc. (ILMN) Unveils AI Breakthrough for Rare Disease Diagnosis
Illumina, Inc. (Nasdaq: Ilmn) introduced Promotetete, a revolutionary AI tool designed to detect the changes in the disease in non -coding genome promoting regions, areas often neglected in clinical diagnostics. Presented in Science, the study shows that Promote could explain up to 6% of cases of rare unheeded diseases, potentially doubling the success of the…